CNX director exercises options, sells 28,800 shares
CNX Resources director William N. Thorndike Jr. exercised stock options to acquire 83,097 common shares at $13.1857 per share and sold 28,800 shares in an open-market transaction at a weighted average price of $38.2481.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CNX Resources director William N. Thorndike Jr. exercised stock options to acquire 83,097 common shares at $13.1857 per share and sold 28,800 shares in an open-market transaction at a weighted average price of $38.2481. After these transactions, he holds 426,585 shares directly, including 2,100 deferred stock units, plus 35,000 shares held by a trust and 50,000 shares through a third-party account, both as indirect interests.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 83,097 | $0.00 | $0.00 |
| Exercise | Common shares, $0.01 par value per share | 83,097 | $13.1857 | $1.10M |
| Sale | Common shares, $0.01 par value per share | 28,800 | $38.2481 | $1.10M |
| holding | Common shares, $0.01 par value per share | -- | -- | -- |
| holding | Common shares, $0.01 par value per share | -- | -- | -- |
Footnotes (4)
- F1. Of the shares owned directly, 2,100 are deferred stock units.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.9900 to $38.4500, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. This stock option, including share amount and exercise price, reflects an exempt anti-dilution adjustment to such award in connection with the 2017 spin-off of the Issuer from CONSOL Energy Inc.
- F4. This stock option vested on May 9, 2017.
Key Figures
Key Terms
deferred stock units financial
weighted average price financial
Stock Option (right to buy) financial
anti-dilution adjustment financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did CNX (CNX) director William N. Thorndike Jr report?
What do the footnotes reveal about the CNX (CNX) director’s stock options and pricing?
AI-generated analysis. How Rhea-AI works. Not financial advice.